Cargando…

Clinical experiences in fungal keratitis caused by Acremonium

PURPOSE: To report the predisposing risk factors, clinical presentation, management, and therapeutic outcomes of fungal keratitis caused by Acremonium. METHODS: This is a retrospective study of cases with Acremonium fungal keratitis that presented to our tertiary referral center between January 2006...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Seong-Jae, Cho, Yong-Wun, Seo, Seong-Wook, Kim, Sun-Joo, Yoo, Ji-Myong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3905093/
https://www.ncbi.nlm.nih.gov/pubmed/24492439
http://dx.doi.org/10.2147/OPTH.S54255
_version_ 1782301288922349568
author Kim, Seong-Jae
Cho, Yong-Wun
Seo, Seong-Wook
Kim, Sun-Joo
Yoo, Ji-Myong
author_facet Kim, Seong-Jae
Cho, Yong-Wun
Seo, Seong-Wook
Kim, Sun-Joo
Yoo, Ji-Myong
author_sort Kim, Seong-Jae
collection PubMed
description PURPOSE: To report the predisposing risk factors, clinical presentation, management, and therapeutic outcomes of fungal keratitis caused by Acremonium. METHODS: This is a retrospective study of cases with Acremonium fungal keratitis that presented to our tertiary referral center between January 2006 and August 2012. Patient demographic and clinical details were determined and reported. RESULTS: Five cases of fungal keratitis from Acremonium species were identified in five patients (three males, two females). The mean age of the patients was of 73.4±5.46 years, with a mean follow-up time of 124±72 days. All patients had a history of corneal trauma with vegetable matter. Four cases were unresponsive to initial treatment (0.2% fluconazole, 0.15% amphotericin B) and required topical 5% natamycin, and, in two out of five cases, topical 1% voriconazole. CONCLUSION: The most common risk factors for Acremonium fungal keratitis was ocular trauma. When a corneal lesion is found to be unresponsive to the initial treatment, we should consider adding or substituting topical natamycin or voriconazole for treatment.
format Online
Article
Text
id pubmed-3905093
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-39050932014-01-30 Clinical experiences in fungal keratitis caused by Acremonium Kim, Seong-Jae Cho, Yong-Wun Seo, Seong-Wook Kim, Sun-Joo Yoo, Ji-Myong Clin Ophthalmol Case Series PURPOSE: To report the predisposing risk factors, clinical presentation, management, and therapeutic outcomes of fungal keratitis caused by Acremonium. METHODS: This is a retrospective study of cases with Acremonium fungal keratitis that presented to our tertiary referral center between January 2006 and August 2012. Patient demographic and clinical details were determined and reported. RESULTS: Five cases of fungal keratitis from Acremonium species were identified in five patients (three males, two females). The mean age of the patients was of 73.4±5.46 years, with a mean follow-up time of 124±72 days. All patients had a history of corneal trauma with vegetable matter. Four cases were unresponsive to initial treatment (0.2% fluconazole, 0.15% amphotericin B) and required topical 5% natamycin, and, in two out of five cases, topical 1% voriconazole. CONCLUSION: The most common risk factors for Acremonium fungal keratitis was ocular trauma. When a corneal lesion is found to be unresponsive to the initial treatment, we should consider adding or substituting topical natamycin or voriconazole for treatment. Dove Medical Press 2014-01-23 /pmc/articles/PMC3905093/ /pubmed/24492439 http://dx.doi.org/10.2147/OPTH.S54255 Text en © 2014 Kim et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Case Series
Kim, Seong-Jae
Cho, Yong-Wun
Seo, Seong-Wook
Kim, Sun-Joo
Yoo, Ji-Myong
Clinical experiences in fungal keratitis caused by Acremonium
title Clinical experiences in fungal keratitis caused by Acremonium
title_full Clinical experiences in fungal keratitis caused by Acremonium
title_fullStr Clinical experiences in fungal keratitis caused by Acremonium
title_full_unstemmed Clinical experiences in fungal keratitis caused by Acremonium
title_short Clinical experiences in fungal keratitis caused by Acremonium
title_sort clinical experiences in fungal keratitis caused by acremonium
topic Case Series
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3905093/
https://www.ncbi.nlm.nih.gov/pubmed/24492439
http://dx.doi.org/10.2147/OPTH.S54255
work_keys_str_mv AT kimseongjae clinicalexperiencesinfungalkeratitiscausedbyacremonium
AT choyongwun clinicalexperiencesinfungalkeratitiscausedbyacremonium
AT seoseongwook clinicalexperiencesinfungalkeratitiscausedbyacremonium
AT kimsunjoo clinicalexperiencesinfungalkeratitiscausedbyacremonium
AT yoojimyong clinicalexperiencesinfungalkeratitiscausedbyacremonium